Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura

American Journal of Hematology

Volumn 84, Issue 10, 2009, Pages 631-635

  Danese, Mark D ^a,d   Lindquist, Karla ^a   Gleeson, Michelle ^a   Deuson, Robert ^b   Mikhael, Joseph ^c  

^a Outcomes Insights Inc   (United States)

^b AMGEN INC   (United States)

^c MAYO CLINIC   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; GENDER; HOSPITAL COST; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT DISCHARGE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; UNITED STATES; YOUNG ADULT;

EID: 70349515542     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21500     Document Type: Article

References (22)

1. Cines DB, McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 2005;56:425-442. (Pubitemid 40299791)
2. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008.
3. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005;106:2244-2251. (Pubitemid 41510792)
4. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
5. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004;104:2623-2634. (Pubitemid 39434940)
6. British Society for Hematology. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children, and in pregnancy. Br J Haematol 2003;120:574-596.
7. Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 2000;160:1630-1638. (Pubitemid 30367902)
8. Cortelazzo S, Finazzi G, Buelli M, et al. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991;77:31-33.
9. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001;97:2549-2554.
10. Arnold DM, Dentali F, Crowther MA, et al. Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 2007;146:25-33. (Pubitemid 351650318)
11. Bussel JB, Kuter DJ, George JN, et al. AMG 531, a thrombopoiesis- stimulating protein, for chronic ITP. N Engl J Meds 2006;355:1672-1681. (Pubitemid 44583957)
12. Bussel JB, Cheng G, Saleh MN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007;357:2237-2247. (Pubitemid 350190754)
13. Vesely SK, Perdue JJ, Rizvi MA, et al. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: A systematic review. Ann Intern Med 2004;140:112-120.
14. Centers for Medicare and Medicaid Services. New, Deleted, and Revised ICD-9-CM Codes - Summary Tables. Available at: http://www.cms.hhs.gov/ ICD9ProviderDiagnosticCodes/07-summarytables.asp. 2007. Accessed date 12 December 2007.
15. Segal JB, Powe NR. Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: A data validation study. Am J Hematol 2004;75:12-17.
16. Guthrie TH Jr, Brannan DP, Prisant LM. Idiopathic thrombocytopenic purpura in the older adult patient. Am J Med Sci 1988;296:17-21. (Pubitemid 18200288)
17. Stasi R, Stipa E, Masi M, et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 1995;98:436-442.
18. Whalen D, Houchens R, Elixhauser A, 2003 HCUP Nationwide Inpatient Sample (NIS) Comparison Report. HCUP Method Series Report # 2006-09. Online December 1, 2006. U.S. Agency for Healthcare Research and Quality. Available: http://www.hcup-us.ahrq.gov/reports/methods.jsp.
19. Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP) 540 Gaither Road, 5th Floor, Rockville, Maryland 20850.
20. Segal JB, Powe NR. Prevalence of immune thrombocytopenia: Analyses of administrative data. J Thromb Haemost 2006;4:2377-2383.
21. US Bureau of Labor Statistics. Available at: http://www.bls.gov/cpi/ #data. Accessed date 6 January 2008.
22. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. New York: Lippincott Williams and Wilkins; 2008.